Loading...
Loading...
INVO| Name | Value |
|---|---|
| Revenues | 348.0K |
| Cost of Revenue | 72.6K |
| Gross Profit | 275.5K |
| Operating Expense | 2,581.9K |
| Operating I/L | -2,306.4K |
| Other Income/Expense | -244.5K |
| Interest Income | 216.6K |
| Pretax | -2,550.9K |
| Income Tax Expense | 461.0K |
| Net Income/Loss | -3,011.9K |
INVO Bioscience, Inc. is a commercial-stage fertility company specializing in assisted reproductive technology solutions. Its flagship product, the INVOcell, is a medical device that facilitates fertilization and early embryo development within the woman's body. The company generates revenue by providing this innovative technology to fertility clinics and healthcare facilities worldwide.
